What is the most likely etiology and appropriate diagnostic and therapeutic approach for a patient presenting with sensorineural hearing loss and myositis?

Sensorineural Hearing Loss and Myositis: Diagnostic and Therapeutic Approach

When a patient presents with both sensorineural hearing loss (SNHL) and myositis, the most likely etiology is an autoimmune/inflammatory disorder, specifically Cogan's syndrome or another systemic autoimmune disease, and immediate corticosteroid therapy should be initiated while pursuing targeted diagnostic workup.

Most Likely Etiologies

The combination of SNHL and myositis strongly suggests:

1. Cogan's syndrome (atypical form) - characterized by audiovestibular symptoms with systemic vasculitis 1, 2
2. Systemic autoimmune diseases - including systemic lupus erythematosus, rheumatoid arthritis, or other vasculitides 3, 4
3. Autoimmune inner ear disease with concurrent inflammatory myopathy 3, 5

The presence of myositis alongside SNHL is a critical red flag indicating systemic autoimmune involvement rather than idiopathic sudden SNHL 1.

Immediate Clinical Assessment

Look specifically for these features in history and examination:

• Bilateral vs unilateral hearing loss - bilateral involvement strongly suggests autoimmune etiology 1
• Rapidity of onset - autoimmune SNHL typically progresses over days to weeks 5, 6
• Fluctuating hearing loss - suggests Ménière's disease, autoimmune inner ear disease, or Cogan's syndrome 1
• Associated symptoms: vertigo, tinnitus, eye symptoms (pain, redness, photophobia suggesting ocular inflammation in Cogan's), oral ulcerations, systemic vasculitis signs 1, 2
• Myositis characteristics: proximal muscle weakness, muscle pain, elevated creatine kinase
• Other focal neurologic findings - headache, cranial nerve palsies, ataxia 1

Perform tuning fork examination (Weber and Rinne tests) to confirm sensorineural rather than conductive hearing loss 1.

Diagnostic Workup Algorithm

1. Immediate Audiometry (within 14 days of symptom onset)

• Pure-tone audiometry to confirm and quantify SNHL 1
• Speech audiometry and impedance testing 6

2. Targeted Laboratory Testing

While routine labs are not recommended for idiopathic SSNHL 1, the presence of myositis mandates specific autoimmune workup:

• Immunologic studies: ANA, RF, anti-dsDNA, complement levels (C3, C4), ANCA
• Inflammatory markers: ESR, CRP
• Myositis-specific antibodies: anti-Jo-1, anti-Mi-2, anti-SRP
• Immunoglobulin levels and lymphocyte populations 5
• Creatine kinase for myositis severity

3. Imaging Studies

• MRI of brain and internal auditory canals to exclude retrocochlear pathology and assess for white matter changes suggesting vasculitis or demyelinating disease 1
• Temporal bone imaging if indicated by examination
• Muscle MRI or EMG to characterize myositis

4. Additional Consultations

• Rheumatology evaluation - essential given the autoimmune presentation 3
• Ophthalmology - to assess for ocular inflammation (Cogan's syndrome) 1

Treatment Protocol

Immediate Therapy (Do Not Delay)

Corticosteroids are the cornerstone of treatment for autoimmune-mediated SNHL and should be initiated urgently 3, 5, 6:

1. High-dose systemic corticosteroids:

   • Methylprednisolone 500 mg IV daily for 3 consecutive days 6
   • Followed by oral prednisone 1 mg/kg/day with gradual taper 5, 6

2. Alternative if oral steroids contraindicated:

   • Intratympanic steroid injections 1

Salvage Therapy (if incomplete recovery at 2-6 weeks)

• Intratympanic steroids 1
• Consider hyperbaric oxygen therapy in combination with steroids (within 2 weeks of onset or up to 1 month) 1

Immunosuppressive Therapy

For confirmed systemic autoimmune disease or refractory cases:

• Cyclophosphamide or other immunosuppressive agents 6, 2
• Coordinate with rheumatology for systemic disease management

What NOT to Do

• Do not routinely prescribe antivirals - insufficient evidence for effectiveness 1
• Do not order routine CT head - not helpful for SNHL diagnosis 1
• Do not delay treatment waiting for complete diagnostic workup - hearing recovery is time-sensitive

Follow-up and Rehabilitation

• Audiometric reassessment at conclusion of treatment and within 6 months 1
• Monitor for treatment response - improvement supports autoimmune diagnosis 5
• Audiologic rehabilitation for residual hearing loss: counseling, amplification options, hearing aids 1
• Long-term rheumatologic follow-up for systemic disease management

Critical Pitfalls to Avoid

1. Mistaking this for idiopathic SSNHL - the presence of myositis demands autoimmune workup, not the "no routine labs" approach of idiopathic cases 1
2. Delaying corticosteroid therapy - autoimmune SNHL can rapidly progress to irreversible deafness 5, 6
3. Treating hearing loss in isolation - failure to recognize and treat the underlying systemic autoimmune disease 3, 4
4. Assuming unilateral presentation excludes autoimmune disease - while bilateral involvement is more common, unilateral presentation can occur 1, 6

The combination of SNHL with myositis represents a medical urgency requiring immediate corticosteroid initiation while pursuing definitive diagnosis, as delayed treatment significantly worsens prognosis for hearing recovery 5, 6.